ArticlePlant cell reports2025
Deciphering the dual resistance pathways to mesosulfuron-methyl in Lolium multiflorum: target-site and non-target-site insights.
Article in Plant cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
key messageLolium multiflorum exhibits resistance to mesosulfuron-methyl through ALS mutations; HZ2 population also shows metabolic resistance through P450 pathways. Lolium multiflorum L., is a weed that frequently appears in wheat fields and is recognized for its strong competitive nature, where it can cause significant damage to grain production. The weeds of L. multiflorum in the wheat fields may have developed resistance to mesosulfuron-methyl. This study explored the response of L. multiflorum populations in certain areas of Henan Province, China, to mesosulfuron-methyl. The study found that, compared to the HX1 sensitive population, the HZ1 and HZ2 populations showed resistance to mesosulfuron-methyl in the full dose-response test, with resistance ratios of 12.38- and 24.19-fold, respectively. Genetic sequencing revealed novel mutations at the Pro-197-Thr and Asp-376-Glu residues of the ALS gene in both resistant populations. A critical finding was the divergent resistance mechanisms between the geographically close populations, with HZ1 resistance solely conferred by target-site mutations and HZ2 exhibiting multiple resistance driven by both target-site mutations and enhanced metabolism mediated by cytochrome P450 monooxygenases. This was conclusively demonstrated by applying the P450 inhibitors malathion and PBO, which reversed resistance in HZ2 by 66.77% and 70.53%, respectively. Furthermore, both resistant populations showed heightened sensitivity to isoproturon, suggesting a potential management strategy. Molecular docking simulations corroborated that the identified mutations reduce herbicide binding affinity. Our findings provide the first evidence of concurrent target-site and non-target-site resistance to mesosulfuron-methyl in Chinese L. multiflorum, offering crucial insights for diagnosing and managing herbicide resistance.
Indexed as
Identifiers
41026230What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.